The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Leflunomide medac



medac Gesellschaft für klinische Spezialpräparate mbHEU/1/10/637/005-009

Main Information

Trade NameLeflunomide medac
Active SubstancesLeflunomide
Dosage FormFilm-coated tablet
Licence Holdermedac Gesellschaft für klinische Spezialpräparate mbH
Licence NumberEU/1/10/637/005-009

Group Information

ATC CodeL04AA Selective immunosuppressants
L04AA13 leflunomide

Status

License statusAuthorised
Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back